Cezary Cybulski
Overview
Explore the profile of Cezary Cybulski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
295
Citations
8277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szwiec M, Tomiczek-Szwiec J, Marciniak W, Derkacz R, Huzarski T, Cybulski C, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075686
Purpose: Among patients treated with neoadjuvant chemotherapy (NAC), a high survival rate is observed for those who experience a pathological complete response (pCR). Various tumor factors are predictive of a...
2.
Debniak T, Baszuk P, Duchnik E, Rowinska K, Boer M, Kiedrowicz M, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002942
The pathogenesis of psoriasis is poorly understood. Increased reactive oxygen species (ROS) and lipid peroxidation are crucial in the inflammatory processes, including psoriasis. Thus, microelements, such as zinc and copper,...
3.
Feszak S, Feszak I, Kluzniak W, Wokolorczyk D, Stempa K, Gliniewicz K, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002208
: Ductal carcinoma in situ (DCIS) is the most common non-invasive form of breast cancer. It is not clear to what extent DCIS is a part of the hereditary breast/ovarian...
4.
Kuligina E, Romanko A, Jankevic T, Martianov A, Ivantsov A, Sokolova T, et al.
Breast Cancer Res Treat
. 2024 Sep;
209(2):341-354.
PMID: 39306605
Purpose: Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC); however, the age at onset is a subject of variation. We hypothesized that the age-related penetrance of...
5.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Hered Cancer Clin Pract
. 2024 Sep;
22(1):19.
PMID: 39300540
Objective: To investigate whether Molybdenum blood level is a marker of cancer risk on BRCA1 carriers. Methods: A prospective cohort study was conducted among 989 initially unaffected women with a...
6.
Lin H, Mazumder H, Sarkar I, Huang P, Eeles R, Kote-Jarai Z, et al.
Sci Rep
. 2024 Aug;
14(1):18677.
PMID: 39134575
Single nucleotide polymorphism (SNP) interactions are the key to improving polygenic risk scores. Previous studies reported several significant SNP-SNP interaction pairs that shared a common SNP to form a cluster,...
7.
Pietrzak S, Marciniak W, Derkacz R, Matuszczak M, Kiljanczyk A, Baszuk P, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123346
Prostate cancer is the most common cancer diagnosed in men and the second leading cause of death in male cancer patients. The WHO suggests that cobalt is involved in the...
8.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Antioxidants (Basel)
. 2024 Jul;
13(7).
PMID: 39061909
Pathogenic mutations in BRCA1 (BReast CAncer gene 1) confer high risks of both breast (up to 70%) and ovarian (up to 40%) cancers. Zinc (Zn) and copper (Cu) are essential...
9.
Kiljanczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Nutrients
. 2024 Jun;
16(11).
PMID: 38892720
Breast cancer and ovarian cancer pose a significant risk for BRCA1 carriers, with limited risk-reduction strategies. While improved screening helps in the early detection of breast cancer, preventive measures remain...
10.
Saner F, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer T, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3481-3498.
PMID: 38837893
Purpose: The purpose of this study was to evaluate RB1 expression and survival across ovarian carcinoma histotypes and how co-occurrence of BRCA1 or BRCA2 (BRCA) alterations and RB1 loss influences...